VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chirodoc who wrote (1936)	8/8/1997 3:59:00 AM
From: Vector1	of 9719

CHIRODOC. been busy. I do not believe there is a clear leader among so acalled pic and shovel companies. the market is very diverse and can be separated into a number of major categories including instruments, genetic systems (gene libraries, vectors, reagents PCR related products, florescent technology, cell biology , nuerology, and separation technologies. Few companies excel in more than one area and some of the best companies are private companies that dominate niches. It is a very competitive business with very very short product life cycles. that being said inovative companies with value added products can achieve 90% gross margins on biologic disposeables. The following are a few names both public and private that are key players. If I have time over the next week or so I will provide more info on their compatitive positions. Promega BioRad PharmaciaBiotech Stratagene Fisher Scientific Ampersham Qiagen Life Technologies BI

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next